Agency Response Letter GRAS Notice No. GRN 000370
Return to inventory listing: GRAS Notice Inventory
CFSAN/Office of Food Additive Safety
April 5, 2011
Susan Cho, Ph.D.
6309 Morning Dew Ct.
Clarksville, MD 21029
Re: GRAS Notice No. GRN 000370
Dear Dr. Cho:
The Food and Drug Administration (FDA) is responding to the notice, dated December 29, 2010, that you submitted on behalf of Shandong Longlive Bio-technology Co., Ltd. (Shandong) in accordance with the agency’s proposed regulation, proposed 21 CFR 170.36 (62 FR 18938; April 17, 1997; Substances Generally Recognized as Safe (GRAS)). FDA received this notice on January 4, 2011, filed it on January 20, 2011, and designated it as GRN No. 000370.
The subject of the notice is xylooligosaccharide. The notice informs FDA of the view of Shandong that xylooligosaccharide is GRAS, through scientific procedures, for use as an ingredient in a variety of foods including baby and toddler foods.
In an e-mail, dated March 28, 2011, on behalf of Shandong, you asked that FDA cease to evaluate the notice. Given your request, we ceased to evaluate the GRAS notice, effective March 28, 2011, the date that we received your e-mail.
In accordance with proposed 21 CFR 170.36(f), a copy of the text of this letter responding to GRN 000370, as well as a copy of the information in this notice that conforms to the information in the GRAS exemption claim (proposed 21 CFR 170.36(c)(1)), is available for public review and copying at www.fda.gov/grasnoticeinventory.
Antonia Mattia, Ph.D.
Division of Biotechnology and GRAS Notice Review
Office of Food Additive Safety
Center for Food Safety and Applied Nutrition